Abstract Anti-epidermal-growth-factor-receptor (EGFR) monoclonal antibodies (mAbs) are of
great significance for RAS and BRAF wild-type metastatic colorectal cancer (mCRC) …

Cancer is one of the greatest dangers to human wellbeing and survival. A key barrier to
effective cancer therapy is development of resistance to anti-cancer medications. In cancer …

Thyroid receptor‐interacting protein 13 (TRIP13), a protein of the AAA‐ATPase family, is
upregulated in various human cancers, including colorectal cancer (CRC). This study …

Colorectal cancer (CRC) is one of the digestive tract malignancies whose early symptoms
are not obvious. This study aimed to identify novel targets for CRC therapy, especially early …

Lung cancer is the most common malignant tumor type and it is associated with poor
prognosis. The identification of potential biomarkers is of great significance for the early …

Colorectal cancer (CRC) accounts for one of the main cancer‐related mortality and morbidity
worldwide. The molecular mechanisms of CRC development have been broadly …

Because survival of patients with metastatic colorectal cancer remain poor, there is an
urgent need to identify potential novel druggable targets that are associated with colorectal …

Thyroid hormone receptor-interacting protein 13 (TRIP13) is involved in cancer progression,
but its role in pancreatic ductal adenocarcinoma (PDAC) is unknown. Thus, we assessed the …

Radiation therapy, a mainstay of treatment for head and neck cancer, is not always curative
due to the development of treatment resistance; additionally, multi-institutional trials have …

Increasing evidence has indicated that thyroid hormone receptor interacting protein 13
(TRIP13) exerts a cancer‐promoting role in a broad spectrum of cancers. However, the …